» Articles » PMID: 17237553

Human Umbilical Cord Blood-derived Mast Cells: a Unique Model for the Study of Neuro-immuno-endocrine Interactions

Overview
Journal Stem Cell Rev
Specialty Cell Biology
Date 2007 Jan 24
PMID 17237553
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Findings obtained using animal models have often failed to reflect the processes involved in human disease. Moreover, human cultured cells do not necessarily function as their actual tissue counterparts. Therefore, there is great demand for sources of human progenitor cells that may be directed to acquire specific tissue characteristics and be available in sufficient quantities to carry out functional and pharmacological studies. Acase in point is the mast cell, well known for its involvement in allergic reactions, but also implicated in inflammatory diseases. Mast cells can be activated by allergens, anaphylatoxins, immunoglobulin-free light chains, superantigens, neuropeptides, and cytokines, leading to selective release of mediators. These could be involved in many inflammatory diseases, such as asthma and atopic dermatitis, which worsen by stress, through activation by local release of corticotropin-releasing hormone or related peptides. Umbilical cord blood and cord matrix-derived mast cell progenitors can be separated magnetically and grown in the presence of stem cell factor, interleukin-6, interleukin-4, and other cytokines to yield distinct mast cell populations. The recent use of live cell array, with its ability to study such interactions rapidly at the single-cell level, provides unique new opportunities for fast output screening of mast cell triggers and inhibitors.

Citing Articles

The gestational power of mast cells in the injured tissue.

Aller M, Arias N, Martinez V, Vergara P, Arias J Inflamm Res. 2017; 67(2):111-116.

PMID: 29101413 DOI: 10.1007/s00011-017-1108-5.


Generation of mast cells from mouse fetus: analysis of differentiation and functionality, and transcriptome profiling using next generation sequencer.

Fukuishi N, Igawa Y, Kunimi T, Hamano H, Toyota M, Takahashi H PLoS One. 2013; 8(4):e60837.

PMID: 23573287 PMC: 3616098. DOI: 10.1371/journal.pone.0060837.


Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation.

Rudich N, Ravid K, Sagi-Eisenberg R Front Immunol. 2012; 3:134.

PMID: 22675325 PMC: 3366457. DOI: 10.3389/fimmu.2012.00134.


Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Suarez A, Feramisco J, Koo J, Steinhoff M Acta Derm Venereol. 2011; 92(1):7-15.

PMID: 22101513 PMC: 3704139. DOI: 10.2340/00015555-1188.


IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.

Hua X, Chason K, Patel J, Naselsky W, Tilley S PLoS One. 2011; 6(9):e24947.

PMID: 21966389 PMC: 3180290. DOI: 10.1371/journal.pone.0024947.


References
1.
Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown L, Claffey K . Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med. 1998; 188(6):1135-45. PMC: 2212544. DOI: 10.1084/jem.188.6.1135. View

2.
Theoharides T, Donelan J, Kandere-Grzybowska K, Konstantinidou A . The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005; 49(1):65-76. DOI: 10.1016/j.brainresrev.2004.11.006. View

3.
Dimitriadou V, Buzzi M, Moskowitz M, Theoharides T . Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience. 1991; 44(1):97-112. DOI: 10.1016/0306-4522(91)90253-k. View

4.
Cao J, Cetrulo C, Theoharides T . Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol. 2005; 69(3):998-1006. DOI: 10.1124/mol.105.019539. View

5.
. Self-reported increase in asthma severity after the September 11 attacks on the World Trade Center--Manhattaan, New York, 2001. MMWR Morb Mortal Wkly Rep. 2002; 51(35):781-4. View